```json
{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in the DJ-1 gene (PARK7) cause autosomal-recessive hereditary Parkinson disease (PD). The most dramatic PD-associated mutation L166P impairs DJ-1 dimer formation and dramatically destabilizes the protein.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that L166P is a PD-associated mutation that impairs DJ-1 dimer formation and destabilizes the protein, thus linking the mutation to a loss-of-function mechanism relevant to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "This study includes protein stability assays and cytotoxicity assays, which assess protein function and cellular viability under stress. These assays are relevant to the disease mechanism of DJ-1 loss-of-function and oxidative stress protection.",
          "judgment": "Yes",
          "reasoning": "The protein stability and cytotoxicity assays are directly relevant to assessing the impact of DJ-1 mutations on protein function and cellular protection, which are key aspects of the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "step_details": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HEK293 and DJ-1-/- MEF cells were cultured in DMEM supplemented with 10% fetal bovine serum without antibiotics. Transient transfections were performed with FuGENE 6, and 2 days later cells were lysed in 1% Triton X-100, 150 мм NaCl, 1 mm EDTA, 10 мм Tris-HCl (pH 7.5) plus Complete protease inhibitor mixture. The cell lines stably expressing wild-type DJ-1 serves as positive/normal control. The use of DJ-1 -/- MEF cells serves as a negative/null control. Error bars delineate standard deviation of triplicate samples.",
          "judgment": "Yes",
          "reasoning": "The study included normal/wild-type control (HEK293 cells and wild-type DJ-1 expressing cell lines) and null/negative controls (DJ-1-/- MEF cells). The experiments were performed in triplicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "step_details": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "L166P was used as control in cytotoxicity assays (see supplemental data).",
          "judgment": "Yes",
          "reasoning": "The study used known pathogenic variant L166P as a control.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "step_details": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Cytotoxicity was measured by LDH release. Error bars delineate standard deviation of triplicate samples; *, p < 0.05; ***, p < 0.001.",
          "judgment": "No",
          "reasoning": "While p-values are provided, the paper does not provide OddsPath calculation or sufficient statistics to calculate it for LDH release assay.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "step_details": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "L166P was used as control in cytotoxicity assays.",
          "judgment": "Yes",
          "reasoning": "There is at least 1 pathogenic variant control (L166P) and no benign variant controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The L166P variant had loss of cytoprotective activity in the cytotoxicity assay. The study included essential controls, replicates, a known pathogenic variant control, but lacked robust statistical analyses to calculate OddsPath. Therefore, we assigned a PS3_supporting strength."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "M",
          "alt": "I",
          "position": "26"
        },
        "variant_string_id": "DJ-1 M26I"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in the DJ-1 gene (PARK7) cause autosomal-recessive hereditary Parkinson disease (PD). The PD-associated mutation M26I within the DJ-1 dimer interface selectively reduced protein expression as well as ASK1 suppression and cytoprotective activity in oxidatively stressed cells.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that M26I is a PD-associated mutation and linked it to reduced protein expression, impaired ASK1 suppression and cytoprotection, thus linking the mutation to a loss-of-function mechanism relevant to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "This study includes protein stability assays, ASK1 suppression assays, and cytotoxicity assays.  These assays are relevant to the disease mechanism of DJ-1 loss-of-function and oxidative stress protection.",
          "judgment": "Yes",
          "reasoning": "The protein stability, ASK1 suppression and cytotoxicity assays are directly relevant to assessing the impact of DJ-1 mutations on protein function and cellular protection, which are key aspects of the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "step_details": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HEK293 and DJ-1-/- MEF cells were cultured in DMEM supplemented with 10% fetal bovine serum without antibiotics. Transient transfections were performed with FuGENE 6, and 2 days later cells were lysed in 1% Triton X-100, 150 мм NaCl, 1 mm EDTA, 10 мм Tris-HCl (pH 7.5) plus Complete protease inhibitor mixture. The cell lines stably expressing wild-type DJ-1 serves as positive/normal control. The use of DJ-1 -/- MEF cells serves as a negative/null control. Error bars delineate standard deviation of triplicate samples.",
          "judgment": "Yes",
          "reasoning": "The study included normal/wild-type control (HEK293 cells and wild-type DJ-1 expressing cell lines) and null/negative controls (DJ-1-/- MEF cells). The experiments were performed in triplicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "step_details": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "L166P was used as control in cytotoxicity assays (see supplemental data).",
          "judgment": "Yes",
          "reasoning": "The study used known pathogenic variant L166P as a control.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "step_details": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Cytotoxicity was measured by LDH release. Error bars delineate standard deviation of triplicate samples; *, p < 0.05; ***, p < 0.001.",
          "judgment": "No",
          "reasoning": "While p-values are provided, the paper does not provide OddsPath calculation or sufficient statistics to calculate it for LDH release assay.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "step_details": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "L166P was used as control in cytotoxicity assays.",
          "judgment": "Yes",
          "reasoning": "There is at least 1 pathogenic variant control (L166P) and no benign variant controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The M26I variant had reduced protein expression, impaired ASK1 suppression and reduced cytoprotective activity. The study included essential controls, replicates, a known pathogenic variant control, but lacked robust statistical analyses to calculate OddsPath. Therefore, we assigned a PS3_supporting strength."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "C",
          "alt": "A",
          "position": "106"
        },
        "variant_string_id": "DJ-1 C106A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Loss-of-function mutations in the DJ-1 gene (PARK7) cause autosomal-recessive hereditary Parkinson disease (PD). The cytoprotective activity of DJ-1 against oxidative stress depends on its cysteine residues. C106A mutation of the central redox site specifically abolished binding to ASK1 and the cytoprotective activity of DJ-1.",
          "judgment": "Yes",
          "reasoning": "The paper clearly states that the cytoprotective activity depends on the cysteine residues, specifically C106A abolished ASK1 binding and cytoprotective activity. The mechanism is linked to a loss-of-function relevant to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "This study includes ASK1 binding assays and cytotoxicity assays. These assays are relevant to the disease mechanism of DJ-1 loss-of-function and oxidative stress protection, involving ASK1 interaction.",
          "judgment": "Yes",
          "reasoning": "The ASK1 binding and cytotoxicity assays are directly relevant to assessing the impact of DJ-1 mutations on protein function and cellular protection and the interation with ASK1, which are key aspects of the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "step_details": "Sub-step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "HEK293 and DJ-1-/- MEF cells were cultured in DMEM supplemented with 10% fetal bovine serum without antibiotics. Transient transfections were performed with FuGENE 6, and 2 days later cells were lysed in 1% Triton X-100, 150 мм NaCl, 1 mm EDTA, 10 мм Tris-HCl (pH 7.5) plus Complete protease inhibitor mixture. The cell lines stably expressing wild-type DJ-1 serves as positive/normal control. The use of DJ-1 -/- MEF cells serves as a negative/null control. Error bars delineate standard deviation of triplicate samples.",
          "judgment": "Yes",
          "reasoning": "The study included normal/wild-type control (HEK293 cells and wild-type DJ-1 expressing cell lines) and null/negative controls (DJ-1-/- MEF cells). The experiments were performed in triplicates.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "step_details": "Sub-step 3c: Variant Controls",
          "extracted_paper_info": "L166P was used as control in cytotoxicity assays (see supplemental data).",
          "judgment": "Yes",
          "reasoning": "The study used known pathogenic variant L166P as a control.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "step_details": "Sub-step 4a: Statistical Analyses",
          "extracted_paper_info": "Cytotoxicity was measured by LDH release. Error bars delineate standard deviation of triplicate samples; *, p < 0.05; ***, p < 0.001.",
          "judgment": "No",
          "reasoning": "While p-values are provided, the paper does not provide OddsPath calculation or sufficient statistics to calculate it for LDH release assay.  There are also no statistics provided for the ASK1 binding assay.",
          "next_step_or_outcome": "Proceed to Sub-step 4b"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "step_details": "Sub-step 4b: No OddsPath Calculation",
          "extracted_paper_info": "L166P was used as control in cytotoxicity assays.",
          "judgment": "Yes",
          "reasoning": "There is at least 1 pathogenic variant control (L166P) and no benign variant controls.",
          "next_step_or_outcome": "Max PS3_supporting"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The C106A variant showed abolished ASK1 binding and abolished cytoprotective activity. The study included essential controls, replicates, a known pathogenic variant control, but lacked robust statistical analyses to calculate OddsPath. Therefore, we assigned a PS3_supporting strength."
    }
  ]
}
```